生育補充劑市場規模、佔有率和成長分析（按成分類型、產品、分銷管道、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，生育補充劑市場規模將達到 22.6 億美元，到 2025 年將達到 24.3 億美元，到 2033 年將達到 44.1 億美元，在預測期（2026-2033 年）內複合年成長率為 7.7%。

隨著不孕不育率的上升，越來越多的人尋求改善生殖健康的替代方法，生育補充劑市場也因此蓬勃發展。人們對膳食補充劑益處的認知不斷提高，以及這些產品供應的日益便利，都大大促進了市場的擴張。然而，市場仍面臨許多挑戰，例如產品品質參差不齊、高成本以及缺乏科學證據支持其有效性，這些都限制了消費者的獲取途徑和信任度。此外，社會對不孕症的歧視也可能阻礙人們尋求治療方案。儘管存在這些障礙，但機會也在不斷湧現，例如電子商務的蓬勃發展、產品種類的日益豐富以及個人化營養的趨勢。隨著越來越多的人尋求非傳統方法來提高生育能力，如果這些挑戰能夠有效解決，市場有望迎來持續成長。

推動生育補充劑市場發展的因素

全球生育力補充劑市場的主要促進因素之一是夫妻對不孕症問題的日益關注和日益普遍。生活方式的改變、環境因素和飲食習慣等因素都會導致生殖健康狀況下降，因此越來越多的個人和夫妻正在尋求有效的解決方案來提高生育能力。這種日益成長的認知得益於教育宣傳活動、社群媒體影響者的推廣以及營養補充益處資訊的普及。此外，消費者越來越重視天然成分和整體療法，以維護生殖健康，這進一步推動了生育力補充劑的需求。

抑制生育補充劑市場的因素

全球生育保健品市場的主要限制因素之一是缺乏統一的監管標準和對各類產品的科學檢驗。儘管許多生育保健品聲稱能夠改善生殖健康，但它們往往缺乏足夠的臨床證據來支持其有效性，這導致消費者和醫療專業人士對其持懷疑態度。這種不確定性可能會阻礙市場成長，因為人們可能不願意投資購買未經證實有效的保健品。此外，產品品質和成分的差異會進一步削弱消費者的信任，限制市場擴張，並促使潛在客戶轉向更成熟的醫療方法。

生育補充劑市場趨勢

受消費者對安全性和減少副作用的偏好所驅動，生育補充劑市場正經歷著向天然和有機產品顯著轉變的趨勢。隨著越來越多的人重視整體健康，對由草藥、維生素和礦物質等天然成分組成的生育補充劑的需求持續成長。 Infolic等產品的日益普及便是這一趨勢的例證，該產品結合了肌醇和葉酸以支持生殖健康，這標誌著人們在飲食選擇方面正朝著更加透明和天然成分的方向發展。因此，市場正在適應這種不斷變化的環境，專注於研發符合消費者價值觀的配方。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術進步

全球生育補充品市場規模（依成分類型分類）及複合年成長率（2026-2033 年）

• 自然的
• 合成

全球生育補充品市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 膠囊
• 藥片
• 軟膠囊
• 粉末
• 液體

全球生育補充品市場規模（依通路分類）及複合年成長率（2026-2033 年）

• OTC
• 處方藥

全球生育補充品市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 男性
• 女士

全球生育補充品市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Fairhaven Health（USA）
• Coast Science（USA）
• Lenus Pharma GesmbH（Austria）
• Active Bio Life Science GmbH（Germany）
• Orthomol（Germany）
• Exeltis USA, Inc.（USA）
• Bionova（India）
• Fertility Nutraceuticals LLC（USA）
• Vitabiotics Ltd.（UK）
• Extreme V, Inc.（USA）
• Xena Bio Herbals Pvt. Ltd.（India）
• Gonadosan Distribution GmbH（Fertilovit）（Austria）
• InnovaMed Ltd.（Amino Expert）（UK）
• Babystart Ltd.（UK）
• Crown Nutraceuticals（USA）
• Sal Nature LLC（USA）
• Yadtech（Israel）
• Prega News（India）
• PlusPlus Lifesciences LLP（India）

結論與建議

Fertility Supplements Market size was valued at USD 2.26 Billion in 2024 and is poised to grow from USD 2.43 Billion in 2025 to USD 4.41 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The fertility supplements market is gaining traction as individuals seek alternative solutions to enhance reproductive health amid rising infertility rates. Increased awareness surrounding the benefits of dietary supplements and their easy availability contribute significantly to market expansion. However, challenges persist, such as inconsistent product quality, high costs, and a lack of scientific evidence supporting efficacy, which dampen accessibility and confidence among consumers. Additionally, stigma surrounding infertility may deter individuals from pursuing treatment options. Despite these hurdles, opportunities are emerging through the growth of e-commerce, a wider variety of products, and the trend towards personalized nutrition. As more people explore non-traditional routes for improving fertility, the market is poised for growth, provided these challenges are addressed effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Supplements Market Segments Analysis

Global Fertility Supplements Market is segmented by Ingredient Type, Product, Distribution Channel, End User and region. Based on Ingredient Type, the market is segmented into Natural and Synthetic. Based on Product, the market is segmented into Capsules, Tablets, Soft gels, Powders and Liquids. Based on Distribution Channel, the market is segmented into OTC and Prescribed. Based on End User, the market is segmented into Men and Women. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Supplements Market

One of the key market drivers for the global fertility supplements market is the rising awareness and increasing prevalence of infertility issues among couples. As lifestyle changes, environmental factors, and dietary habits contribute to decreased reproductive health, more individuals and couples are seeking effective solutions to enhance fertility. This growing awareness is bolstered by educational initiatives, social media influence, and the availability of information regarding the benefits of nutritional support. Additionally, the trend towards natural and holistic approaches to health and wellness further fuels demand for fertility supplements, as consumers increasingly prioritize natural ingredients and holistic treatment options to support reproductive health.

Restraints in the Fertility Supplements Market

One of the key market restraints for the global fertility supplements market is the lack of regulatory standardization and scientific validation of various products. Many fertility supplements claim to enhance reproductive health but often lack sufficient clinical evidence to support their efficacy, leading to skepticism among consumers and healthcare professionals. This uncertainty can hinder market growth as individuals may be reluctant to invest in supplements without proven benefits. Additionally, the varying quality and ingredients of products can further complicate consumer trust, limiting market expansion and driving potential customers towards more established medical treatments.

Market Trends of the Fertility Supplements Market

The fertility supplements market is experiencing a notable shift towards natural and organic products, driven by consumer preferences for perceived safety and reduced side effects. As individuals prioritize holistic approaches to health, the demand for fertility supplements composed of natural ingredients, including herbs, vitamins, and minerals, continues to rise. This trend is underscored by the increasing popularity of products like Infolic, which combines myo-inositol and folic acid to support reproductive health, showcasing a broader movement towards transparency and natural composition in dietary choices. Consequently, the market is adapting to this evolving landscape by focusing on formulations that align with these consumer values.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Fertility Supplements Market Size by Ingredient Type & CAGR (2026-2033)

• Market Overview
• Natural
• Synthetic

Global Fertility Supplements Market Size by Product & CAGR (2026-2033)

• Market Overview
• Capsules
• Tablets
• Soft gels
• Powders
• Liquids

Global Fertility Supplements Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• OTC
• Prescribed

Global Fertility Supplements Market Size by End User & CAGR (2026-2033)

• Market Overview
• Men
• Women

Global Fertility Supplements Market Size & CAGR (2026-2033)

• North America (Ingredient Type, Product, Distribution Channel, End User)
  • US
  • Canada
• Europe (Ingredient Type, Product, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Ingredient Type, Product, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Ingredient Type, Product, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Ingredient Type, Product, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fairhaven Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coast Science (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lenus Pharma GesmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Active Bio Life Science GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthomol (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exeltis USA, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionova (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fertility Nutraceuticals LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitabiotics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Extreme V, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xena Bio Herbals Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gonadosan Distribution GmbH (Fertilovit) (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InnovaMed Ltd. (Amino Expert) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Babystart Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Nutraceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sal Nature LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yadtech (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prega News (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PlusPlus Lifesciences LLP (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations